top of page
Nelson Advisors > European HealthTech & MedTech


The Rise of the Healthcare AI Native Hyperscaler: Strategic Transformation of Clinical and Research Value Chains
The healthcare landscape in 2026 has transitioned from a period of experimental artificial intelligence adoption to a structural realignment centered on AI-native hyperscale infrastructure. This shift is characterised by the emergence of a specific class of organisations, the Healthcare AI Native Hyperscalers, who command the massive computational power, specialised domain models, and proprietary data estates required to operate at the intersection of biology and clinical pra
Nelson Advisors
Mar 1912 min read


The Digital Musculoskeletal (MSK) Market Transformation Forecast 2026–2035
The global healthcare landscape is rapidly converging upon a singular, undeniable crisis point regarding musculoskeletal (MSK) health, creating a definitive "before and after" scenario centered around the year 2026. For decades, MSK disorders, encompassing conditions ranging from non-specific low back pain (LBP) to complex post-surgical rehabilitation, have served as the silent epidemic of the industrialised world. However, as we approach the latter half of the 2020s, the con
Nelson Advisors
Dec 13, 202514 min read


Five Megatrends and Predictions for European HealthTech and MedTech in 2026
This report provides strategic foresight into five dominant mega trends shaping the European HealthTech and MedTech landscape for 2026. The year marks a critical nexus where groundbreaking technological acceleration meets definitive regulatory enforcement, primarily through the EU AI Act and the European Health Data Space (EHDS) regulation.
Nelson Advisors
Oct 12, 202520 min read


The 3 D’s in HealthTech 2026: Strategic Convergence of Disintermediation, Differentiation and Diversification
The convergence of a disciplined financial market, heightened buyer demands for measurable ROI, and regulatory mandates for digital interoperability creates three dominant strategic pressures for HealthTech as we look ahead into 2026: Disintermediation, Differentiation and Diversification.
Lloyd Price
Oct 4, 202514 min read
bottom of page